scholarly journals Effects of Dietary Glucose and Fructose on Copper, Iron, and Zinc Metabolism Parameters in Humans

Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2581 ◽  
Author(s):  
Nathaniel H. O. Harder ◽  
Bettina Hieronimus ◽  
Kimber L. Stanhope ◽  
Noreene M. Shibata ◽  
Vivien Lee ◽  
...  

Alterations of transition metal levels have been associated with obesity, hepatic steatosis, and metabolic syndrome in humans. Studies in animals indicate an association between dietary sugars and copper metabolism. Our group has conducted a study in which young adults consumed beverages sweetened with glucose, fructose, high fructose corn syrup (HFCS), or aspartame for two weeks and has reported that consumption of both fructose- and HFCS-sweetened beverages increased cardiovascular disease risk factors. Baseline and intervention serum samples from 107 participants of this study were measured for copper metabolism (copper, ceruloplasmin ferroxidase activity, ceruloplasmin protein), zinc levels, and iron metabolism (iron, ferritin, and transferrin) parameters. Fructose and/or glucose consumption were associated with decreased ceruloplasmin ferroxidase activity and serum copper and zinc concentrations. Ceruloplasmin protein levels did not change in response to intervention. The changes in copper concentrations were correlated with zinc, but not with iron. The decreases in copper, ceruloplasmin ferroxidase activity, ferritin, and transferrin were inversely associated with the increases in metabolic risk factors associated with sugar consumption, specifically, apolipoprotein CIII, triglycerides, or post-meal glucose, insulin, and lactate responses. These findings are the first evidence that consumption of sugar-sweetened beverages can alter clinical parameters of transition metal metabolism in healthy subjects.

2017 ◽  
Vol 37 (suppl_1) ◽  
Author(s):  
John R Barr ◽  
Zsuzsanna Kuklenyik ◽  
Michael Gardner ◽  
Christopher Toth ◽  
Bryan A Parks ◽  
...  

A multiplexed, quantitative analytical workflow was applied to 120 fasting human serum samples collected from 30 normolipidemic, and 90 dyslipidemic donors. The analysis included separation by asymmetric flow field-flow fractionation while collecting fractions with ~1 nm increments of 7-15 nm (HDL), 20-30 nm (LDL) and greater than 30 nm lipoproteins. Size separation was followed by concentration measurements in each size fraction for non-polar lipids (FC, CE and TG), polar lipids (PC, SM, PE and PI), and apolipoproteins (apos A-I, A-II, A-IV, B, C-I, C-II, C-III and E); using three parallel, high throughput, quantitative liquid chromatography-tandem mass spectrometry methods developed in our laboratory. The average hydrodynamic size in each size fraction was also determined by dynamic light scattering. Measuring all major lipid and protein components and the size in all fractions allowed volumetric estimation of lipoprotein particle numbers (Lp-P). In the LDL size range of 22-26 nm, the calculated mean (N=120 samples) of the average (N=5 fraction/sample) apoB/LDL-P was 1.00 (Stdev=0.31, N=120). The resulting highly comprehensive data set allowed the evaluation of correlations between cardiovascular disease (CVD) risk factors and metabolic pathway specific indicators. For example, multivariate modelling of Total-TG/HDL-C ratios (1.5-17.5) showed negative correlation with HDL-apoC-III/LDL-apoC-III ratios.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1491-P
Author(s):  
APRILL DAWSON ◽  
EMMA GARACCI ◽  
MUKOSO N. OZIEH ◽  
REBEKAH J. WALKER ◽  
LEONARD E. EGEDE

Sign in / Sign up

Export Citation Format

Share Document